The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...
Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making ...
is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic. Both are sold by Danish drug giant Novo Nordisk. The generic liraglutide is sold by Hikma ...
is an earlier iteration in the same class of drug as semaglutide, the active ingredient in Ozempic. The US Food and Drug Administration on Monday approved a generic version of the daily injectable ...